Navigation Links
For Tough Head Lice, Pill Tops Lotion
Date:3/10/2010

Ivermectin may offer alternative for hard-to-treat infestations, study shows,,,,,,

WEDNESDAY, March 10 (HealthDay News)-- In children with hard-to-treat head lice, the oral medication ivermectin is more effective than the standard treatment, the topical cream malathion, new research finds.

The study, published in the March 11 issue of the New England Journal of Medicine, found that 95 percent of those treated with ivermectin were lice-free after two weeks compared to 85 percent of those using malathion.

"Ivermectin may be a good alternative to malathion when topical insecticide resistance is suspected," the study authors wrote.

The researchers caution that ivermectin generally shouldn't be used as a first-line treatment, but instead suggest that it be reserved for treatment-resistant lice. Overuse of ivermectin might lead to lice developing resistance to this medication as well.

Between 6 million and 12 million American schoolchildren are infested with head lice each year, the U.S. Centers for Disease Control and Prevention reports. Worldwide, as many as 100 million people contract head lice annually, according to background information in the study.

Although most lice infestations respond well to over-the-counter remedies, some lice have become resistant to these medications. In some cases, lice have also developed a resistance to the topical prescription medication malathion.

Ivermectin, an oral anti-parasitic drug, has been used to treat other parasitic infections, such as scabies. A previous trial on ivermectin found that a dose of 200 micrograms per kilogram of body weight was only effective in killing lice in about one out of four people, according to the study.

The current study was designed to assess the efficacy of ivermectin at twice that dose -- 400 micrograms per kilogram of body weight -- and to compare it to the standard treatment for difficult-to-treat lice.

A total of 812 children were recruited for the study. Their average age was 10. The children were put into one of two treatment groups. One group received ivermectin on days one and eight at a dose equivalent to 400 micrograms per kilogram, while the other group was treated with malathion lotion on the same days. Study medications were provided by the drug manufacturers.

Each group was also given a placebo equivalent. Those in the ivermectin group were treated with a similarly-scented lotion on treatment days, and those in the malathion group were given placebo pills on treatment days.

No other lice treatments were permitted, not even combing lice eggs (nits) from the hair.

On day 15, the researchers examined the children for evidence of continued infestation. They found that ivermectin was more effective, with 95 percent of the children lice-free. In the malathion group, 85 percent of the children treated were lice-free.

The researchers found no significant differences in the frequency of adverse events related to treatment, according to the study.

"Ivermectin looks like another tool against head lice, but there are still a number of questions to be answered," said Dr. Mark Diamond, a pediatrician affiliated with Children's Hospital of Pittsburgh. "The risk of side effects isn't totally clear, and a systemic drug vs. a topical medication is clearly a change in process. Plus, I have no idea of the cost."

One advantage of ivermectin might be that it's easier to administer, he said. "Lotions and shampoos are messy, and if all other factors are equal, parents might prefer an oral medication," said Diamond.

The good news about lice, he said, is that "a head lice infection is not serious, and it doesn't lead to other harmful diseases or complications." And, he said, most children can be effectively treated with over-the-counter medications and careful combing to remove nits from their hair.

More information

Learn more about head lice from the U.S. Centers for Disease Control and Prevention.



SOURCES: Mark Diamond, M.D., pediatrician, Pittsburgh; March 11, 2010, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Gender-Neutral Flex-Friendly Certification Makes the Business Case for Flex Even in a Tough Economy.
2. Mt. Everest Summiter Gary Guller (With One Arm) To Race Across Sahara in "The World's Toughest Stage Race"
3. Current Blood Thinners Face Tough Competition
4. WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan
5. Firmex Achieves 237% Annual Revenue Growth Despite Tough M&A Environment in 2009
6. New Website Giving Away Diabetes-Friendly Super Bowl Munchies Recipes to Tackle America's Toughest Health Problem
7. Children's Health Insurance Program Helping Families Get Through Tough Times
8. 2010: A Tough Year Ahead for Discharge Planners, but Help Is Available
9. Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing
10. In Tough Economy SEIU-UHW Members Wage Increases Far Exceed the National Average
11. After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology: